HSY
41
6
STI
7
-4
MMM
57
-6
BMY
76
2
MUR
38
-6
WDC
65
-3
ZTS
17
5
HAS
61
-2
WYNN
49
15
CF
48
-2
VIX
33
4
CRM
50
-9
DAL
72
2
PCG
69
3
LUV
70
2
UPS
38
-2
AAL
54
3
DVN
43
-5
AEE
58
8
SLG
37
6
HSY
41
6
STI
7
-4
MMM
57
-6
BMY
76
2
MUR
38
-6
WDC
65
-3
ZTS
17
5
HAS
61
-2
WYNN
49
15
CF
48
-2
VIX
33
4
CRM
50
-9
DAL
72
2
PCG
69
3
LUV
70
2
UPS
38
-2
AAL
54
3
DVN
43
-5
AEE
58
8
SLG
37
6
Financhill
Back

Credit Suisse Asset Management Income Fund Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison

Sell
33

CIK
Credit Suisse Asset Management Income Fund Inc.

Last Price:
$2.82
Seasonality Move:
2.58%
Sell
33

ZBIO
Zenas BioPharma, Inc.

Last Price:
$36.94
Seasonality Move:
-8.13%
Sell
33
Credit Suisse Asset Management Income Fund Inc. (CIK) is a Sell

Is Credit Suisse Asset Management Income Fund Inc. a Buy, Sell or Hold?

  • The current Credit Suisse Asset Management Income Fund Inc. [CIK] share price is $2.80. The Score for CIK is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • CIK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Zenas BioPharma, Inc. (ZBIO) is a Sell

Is Zenas BioPharma, Inc. a Buy, Sell or Hold?

  • The current Zenas BioPharma, Inc. [ZBIO] share price is $32.59. The Score for ZBIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CIK Stock Price Chart

What is Credit Suisse Asset Management Income Fund Inc.'s stock price today?

ZBIO Stock Price Chart

What is Zenas BioPharma, Inc.'s stock price today?

  • The Zenas BioPharma, Inc. share price today is $32.59
    The current trend is moderately bullish and ZBIO is experiencing selling pressure, which indicates risk of future bearish movement.

CIK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 42.57 Sell
Chaikin Money Flow: 298398 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.78 - 2.84) Sell
Bollinger Bands (100): (2.84 - 2.98) Sell

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.39 Buy
Relative Strength Index (14 RSI): 42.51 Sell
Chaikin Money Flow: -433025 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.8 - 39.38) Sell
Bollinger Bands (100): (16.79 - 33.43) Buy

CIK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.82 Sell
20-day SMA: 2.81 Sell
50-day SMA: 2.85 Sell
200-day SMA: 2.89 Sell
8-day EMA: 2.82 Sell
20-day EMA: 2.82 Sell
50-day EMA: 2.85 Sell
200-day EMA: 2.9 Sell

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.44 Sell
20-day SMA: 37.66 Sell
50-day SMA: 32.27 Buy
200-day SMA: 17.45 Buy
8-day EMA: 37.61 Sell
20-day EMA: 34.32 Sell
50-day EMA: 23.15 Buy
200-day EMA: 7.97 Buy

Credit Suisse Asset Management Income Fund Inc. Earnings Growth & CIK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.65 per share, and an increase next year of $0.59 per share.

Credit Suisse Asset Management Income Fund Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):